Clinical trial
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine…
NCT00002073 · Ortho Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00002073 |
|---|---|
| Title | A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy |
| Official title | A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy |
| Lead sponsor | Ortho Pharmaceuticals, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Cytopenias |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: